Freestone Capital Holdings’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-43
Closed -$1.97K 442
2020
Q4
$1.97K Hold
43
﹤0.01% 1145
2020
Q3
$1.43K Buy
+43
New +$1.37K ﹤0.01% 1074

Other funds holding AVNS

Freestone Capital Holdings's AVNS Position: Q1 2021 in Review

Freestone Capital Holdings sold out of Avanos Medical (AVNS) in Q1 2021, closing a stake of 43 shares — an estimated $1.97K sold.

Freestone Capital Holdings first reported a position in AVNS in Q3 2020 and held it in 2 quarters. The position peaked at $1.97K in Q4 2020. 291 funds tracked by Wall St. Rank hold AVNS as of Q1 2021.

  • Freestone Capital Holdings reported no remaining Avanos Medical position as of Q1 2021 after selling out during the quarter.
  • Freestone Capital Holdings sold 43 Avanos Medical shares in Q1 2021, an estimated $1.97K.
  • Freestone Capital Holdings first reported a position in Avanos Medical in Q3 2020 and held it in 2 quarters.
  • Freestone Capital Holdings's Avanos Medical position peaked at $1.97K in Q4 2020.
  • 291 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2021.

Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.